New hope for non-Hodgkins lymphoma patients AbbVie to launch epcoritamab in the United Arab Emirates –  UAE is the first country after the country of origin (US) to be granted conditional regulatory approval Dubai, United Arab Emirates, Sep. 12, 2023 TEPKINLY™ (epcoritamab) has received conditional regulatory approval in the United Arab Emirates (UAE) on August … Continue reading AbbVie to launch epcoritamab in the United Arab Emirates